Tuberculosis (TB) remains endemic in our region and is the second leading major cause of death in both Papua New Guinea (PNG) and Indonesia. Menzies has partnered with the Burnet Institute and other stakeholders (with Burnet as the lead) to deliver PRIME-TB. The goal is that ‘Public health solutions are developed through a multi-country platform to catalyse the scale-up of innovations to meet TB elimination targets in the Indo-Pacific Region’.

PRIME-TB will develop four “fast-track” sites (Yogyakarta, Port Moresby, Mimika and Daru) as knowledge and innovation hubs in TB elimination that will catalyse implementation, develop the workforce, strengthen systems, including addressing drug resistant TB outbreaks.

  1. Knowledge is generated, and innovative solutions are tested for the micro-elimination of TB in PNG and Indonesia.
  2. Sustainable capacity is developed in public health systems, key institutions and people leaders for the micro-elimination of TB in PNG and Indonesia.
  3. Develop a regional platform and partnerships for knowledge sharing of best practice for TB elimination across PNG, Indonesia, Timor-Leste and Australia.
Chief investigator:
Project manager:
  • Rebecca Slade
Contact information:

For more information contact Christopher Lowbridge or Rebecca Slade.

Project dates:

The project commenced in March 2020 and is due for completion in June 2022.